Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BioHorizons Camlog Present at EAO Congress in Berlin

BioHorizons Camlog Present at EAO Congress in Berlin

28th July 2023

BioHorizons Camlog have announced that it will participate in the European Association for Osseointegration (EAO) 2023 Congress, held in Berlin from September 28 to 30, 2023. According to EAO, more than 5,000 visitors from all over the world are expected at this year’s event. For the first time, it will also be possible to attend EAO programmes online, whereby all participants will be actively involved in the broadcasts and discussions.

At the BioHorizons Camlog stand H09, participants can discover the company’s broad portfolio of innovative and holistic regenerative solutions in biomaterials and implant systems. BioHorizons Camlog has established itself as one of the leading suppliers of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions which helps dentists to provide patients with the optimum treatment.

BioHorizons Camlog will also host two workshops at EAO.

On Friday, September 29, 2023, Prof. Daniel Rothamel (Germany) will speak on allogeneic bone substitute materials for bone regeneration in his workshop. He will demonstrate fundamentals and techniques of hard tissue augmentation with allografts based on patient cases and hands-on exercises. The practical exercises on the model include the application of allogeneic materials in particulate form, block augmentation, and the shell technique.

Later that day, Dr. Robert Oretti (United Kingdom) will present the concept of open healing and demonstrate options for its application in modern implant dentistry. In this hands-on workshop, participants will learn to choose between the different treatment options, focusing on the steps to achieve passive closure over the bone graft without compromising the muco-gingival line.

Between the two workshops, Prof. Rothamel and Dr. Oretti will provide insight into allogeneic bone substitute materials in an industry forum, as there is growing evidence that allogeneic grafts may be a safe alternative to autologous grafts in implant therapy. In this forum, they will be presenting new data and therapeutic concepts on allografts, indicating the potential clinical relevance of these materials in implant dentistry.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.